The global market for Cord Blood Stem Cells was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cord Blood Stem Cells, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cord Blood Stem Cells by region & country, by Type, and by Application.
The Cord Blood Stem Cells market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cord Blood Stem Cells.
Market Segmentation
By Company
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics Inc.
Athersys Inc.
Geron Corporation
Neostem Inc.
CBR Systems, Inc.
Cordlife
Cryo-Cell
Cryo-Save AG (A Group of Esperite)
Lifecell
Stemcyte
Viacord
Smart Cells International Ltd.
Cryoviva India
Cordvida
China Cord Blood Corporation
Segment by Type:
Allogeneic Stem Cell
Autologous Stem Cell
Segment by Application
Autoimmune Diseases
Immunodeficiencies
Malignancies,Caners
Solid Tumors
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cord Blood Stem Cells manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cord Blood Stem Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cord Blood Stem Cells in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Cord Blood Stem Cells Product Introduction
1.2 Global Cord Blood Stem Cells Market Size Forecast
1.3 Cord Blood Stem Cells Market Trends & Drivers
1.3.1 Cord Blood Stem Cells Industry Trends
1.3.2 Cord Blood Stem Cells Market Drivers & Opportunity
1.3.3 Cord Blood Stem Cells Market Challenges
1.3.4 Cord Blood Stem Cells Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cord Blood Stem Cells Players Revenue Ranking (2023)
2.2 Global Cord Blood Stem Cells Revenue by Company (2019-2024)
2.3 Key Companies Cord Blood Stem Cells Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cord Blood Stem Cells Product Offered
2.5 Key Companies Time to Begin Mass Production of Cord Blood Stem Cells
2.6 Cord Blood Stem Cells Market Competitive Analysis
2.6.1 Cord Blood Stem Cells Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cord Blood Stem Cells Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cord Blood Stem Cells as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Allogeneic Stem Cell
3.1.2 Autologous Stem Cell
3.2 Global Cord Blood Stem Cells Sales Value by Type
3.2.1 Global Cord Blood Stem Cells Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cord Blood Stem Cells Sales Value, by Type (2019-2030)
3.2.3 Global Cord Blood Stem Cells Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Autoimmune Diseases
4.1.2 Immunodeficiencies
4.1.3 Malignancies,Caners
4.1.4 Solid Tumors
4.1.5 Others
4.2 Global Cord Blood Stem Cells Sales Value by Application
4.2.1 Global Cord Blood Stem Cells Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cord Blood Stem Cells Sales Value, by Application (2019-2030)
4.2.3 Global Cord Blood Stem Cells Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cord Blood Stem Cells Sales Value by Region
5.1.1 Global Cord Blood Stem Cells Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cord Blood Stem Cells Sales Value by Region (2019-2024)
5.1.3 Global Cord Blood Stem Cells Sales Value by Region (2025-2030)
5.1.4 Global Cord Blood Stem Cells Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cord Blood Stem Cells Sales Value, 2019-2030
5.2.2 North America Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cord Blood Stem Cells Sales Value, 2019-2030
5.3.2 Europe Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cord Blood Stem Cells Sales Value, 2019-2030
5.4.2 Asia Pacific Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cord Blood Stem Cells Sales Value, 2019-2030
5.5.2 South America Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cord Blood Stem Cells Sales Value, 2019-2030
5.6.2 Middle East & Africa Cord Blood Stem Cells Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cord Blood Stem Cells Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cord Blood Stem Cells Sales Value
6.3 United States
6.3.1 United States Cord Blood Stem Cells Sales Value, 2019-2030
6.3.2 United States Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cord Blood Stem Cells Sales Value, 2019-2030
6.4.2 Europe Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cord Blood Stem Cells Sales Value, 2019-2030
6.5.2 China Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cord Blood Stem Cells Sales Value, 2019-2030
6.6.2 Japan Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cord Blood Stem Cells Sales Value, 2019-2030
6.7.2 South Korea Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cord Blood Stem Cells Sales Value, 2019-2030
6.8.2 Southeast Asia Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cord Blood Stem Cells Sales Value, 2019-2030
6.9.2 India Cord Blood Stem Cells Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cord Blood Stem Cells Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Advanced Cell Technology
7.1.1 Advanced Cell Technology Profile
7.1.2 Advanced Cell Technology Main Business
7.1.3 Advanced Cell Technology Cord Blood Stem Cells Products, Services and Solutions
7.1.4 Advanced Cell Technology Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.1.5 Advanced Cell Technology Recent Developments
7.2 California Stem Cell
7.2.1 California Stem Cell Profile
7.2.2 California Stem Cell Main Business
7.2.3 California Stem Cell Cord Blood Stem Cells Products, Services and Solutions
7.2.4 California Stem Cell Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.2.5 California Stem Cell Recent Developments
7.3 Cytori Therapeutics
7.3.1 Cytori Therapeutics Profile
7.3.2 Cytori Therapeutics Main Business
7.3.3 Cytori Therapeutics Cord Blood Stem Cells Products, Services and Solutions
7.3.4 Cytori Therapeutics Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.3.5 Mesoblast Limited Recent Developments
7.4 Mesoblast Limited
7.4.1 Mesoblast Limited Profile
7.4.2 Mesoblast Limited Main Business
7.4.3 Mesoblast Limited Cord Blood Stem Cells Products, Services and Solutions
7.4.4 Mesoblast Limited Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.4.5 Mesoblast Limited Recent Developments
7.5 Opexa Therapeutics Inc.
7.5.1 Opexa Therapeutics Inc. Profile
7.5.2 Opexa Therapeutics Inc. Main Business
7.5.3 Opexa Therapeutics Inc. Cord Blood Stem Cells Products, Services and Solutions
7.5.4 Opexa Therapeutics Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.5.5 Opexa Therapeutics Inc. Recent Developments
7.6 Athersys Inc.
7.6.1 Athersys Inc. Profile
7.6.2 Athersys Inc. Main Business
7.6.3 Athersys Inc. Cord Blood Stem Cells Products, Services and Solutions
7.6.4 Athersys Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.6.5 Athersys Inc. Recent Developments
7.7 Geron Corporation
7.7.1 Geron Corporation Profile
7.7.2 Geron Corporation Main Business
7.7.3 Geron Corporation Cord Blood Stem Cells Products, Services and Solutions
7.7.4 Geron Corporation Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.7.5 Geron Corporation Recent Developments
7.8 Neostem Inc.
7.8.1 Neostem Inc. Profile
7.8.2 Neostem Inc. Main Business
7.8.3 Neostem Inc. Cord Blood Stem Cells Products, Services and Solutions
7.8.4 Neostem Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.8.5 Neostem Inc. Recent Developments
7.9 CBR Systems, Inc.
7.9.1 CBR Systems, Inc. Profile
7.9.2 CBR Systems, Inc. Main Business
7.9.3 CBR Systems, Inc. Cord Blood Stem Cells Products, Services and Solutions
7.9.4 CBR Systems, Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.9.5 CBR Systems, Inc. Recent Developments
7.10 Cordlife
7.10.1 Cordlife Profile
7.10.2 Cordlife Main Business
7.10.3 Cordlife Cord Blood Stem Cells Products, Services and Solutions
7.10.4 Cordlife Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.10.5 Cordlife Recent Developments
7.11 Cryo-Cell
7.11.1 Cryo-Cell Profile
7.11.2 Cryo-Cell Main Business
7.11.3 Cryo-Cell Cord Blood Stem Cells Products, Services and Solutions
7.11.4 Cryo-Cell Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.11.5 Cryo-Cell Recent Developments
7.12 Cryo-Save AG (A Group of Esperite)
7.12.1 Cryo-Save AG (A Group of Esperite) Profile
7.12.2 Cryo-Save AG (A Group of Esperite) Main Business
7.12.3 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Products, Services and Solutions
7.12.4 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.12.5 Cryo-Save AG (A Group of Esperite) Recent Developments
7.13 Lifecell
7.13.1 Lifecell Profile
7.13.2 Lifecell Main Business
7.13.3 Lifecell Cord Blood Stem Cells Products, Services and Solutions
7.13.4 Lifecell Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.13.5 Lifecell Recent Developments
7.14 Stemcyte
7.14.1 Stemcyte Profile
7.14.2 Stemcyte Main Business
7.14.3 Stemcyte Cord Blood Stem Cells Products, Services and Solutions
7.14.4 Stemcyte Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.14.5 Stemcyte Recent Developments
7.15 Viacord
7.15.1 Viacord Profile
7.15.2 Viacord Main Business
7.15.3 Viacord Cord Blood Stem Cells Products, Services and Solutions
7.15.4 Viacord Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.15.5 Viacord Recent Developments
7.16 Smart Cells International Ltd.
7.16.1 Smart Cells International Ltd. Profile
7.16.2 Smart Cells International Ltd. Main Business
7.16.3 Smart Cells International Ltd. Cord Blood Stem Cells Products, Services and Solutions
7.16.4 Smart Cells International Ltd. Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.16.5 Smart Cells International Ltd. Recent Developments
7.17 Cryoviva India
7.17.1 Cryoviva India Profile
7.17.2 Cryoviva India Main Business
7.17.3 Cryoviva India Cord Blood Stem Cells Products, Services and Solutions
7.17.4 Cryoviva India Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.17.5 Cryoviva India Recent Developments
7.18 Cordvida
7.18.1 Cordvida Profile
7.18.2 Cordvida Main Business
7.18.3 Cordvida Cord Blood Stem Cells Products, Services and Solutions
7.18.4 Cordvida Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.18.5 Cordvida Recent Developments
7.19 China Cord Blood Corporation
7.19.1 China Cord Blood Corporation Profile
7.19.2 China Cord Blood Corporation Main Business
7.19.3 China Cord Blood Corporation Cord Blood Stem Cells Products, Services and Solutions
7.19.4 China Cord Blood Corporation Cord Blood Stem Cells Revenue (US$ Million) & (2019-2024)
7.19.5 China Cord Blood Corporation Recent Developments
8 Industry Chain Analysis
8.1 Cord Blood Stem Cells Industrial Chain
8.2 Cord Blood Stem Cells Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cord Blood Stem Cells Sales Model
8.5.2 Sales Channel
8.5.3 Cord Blood Stem Cells Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics Inc.
Athersys Inc.
Geron Corporation
Neostem Inc.
CBR Systems, Inc.
Cordlife
Cryo-Cell
Cryo-Save AG (A Group of Esperite)
Lifecell
Stemcyte
Viacord
Smart Cells International Ltd.
Cryoviva India
Cordvida
China Cord Blood Corporation
听
听
*If Applicable.
